Literature DB >> 22605940

Cancer treatment - objectives and quality of life issues.

Farhat Aziz Khan1, Shad Salim Akhtar, Muhammad Kamil Sheikh.   

Abstract

The first aim of cancer treatment is to acheive a cure, and when cure is not possible, a good palliation (life prolongation and relief of sufferings) is warranted. This article highlights the aim of cancer treatment and also attempts to assess the issues of quality of life experienced as a result of the disease and its treatment. Palliative therapy should be less intensive than radical treatment and should cause less morbidity than disease itself. It must be effective, completed in a short time and should be tolerable. It is also essential for a physician to give a clear explanation of illness to the patient and realistic advice regarding the likely outcome of therapy and the long and short term morbidities which may occur. The patient may opt for a palliative treatment with a reduced chance of cure but a better quality of life than accepting a radical treatment with a potentially higher degree of morbidity. Quality of life in oncology practice should be seen as a process and as a part of this process it seems sensible to pursue several different lines of questionnaire development rather than constructing one 'perfect" quality of life instrument.

Entities:  

Keywords:  QOL issues; cancer treatment

Year:  2005        PMID: 22605940      PMCID: PMC3349406     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  9 in total

Review 1.  Quality of life end points in cancer clinical trials: review and recommendations.

Authors:  C M Moinpour; P Feigl; B Metch; K A Hayden; F L Meyskens; J Crowley
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

2.  The influence of the extent of surgery on the neurological function and survival in malignant glioma. A retrospective analysis in 243 patients.

Authors:  C J Vecht; C J Avezaat; W L van Putten; W M Eijkenboom; S Z Stefanko
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

Review 3.  Quality of life: what is it? How should it be measured?

Authors:  N K Aaronson
Journal:  Oncology (Williston Park)       Date:  1988-05       Impact factor: 2.990

4.  The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group.

Authors:  J R Wood; S B Green; W R Shapiro
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

5.  Long term survival among patients with malignant brain tumors.

Authors:  A N Lieberman; S H Foo; J Ransohoff; A Wise; A George; W Gordon; R Walker
Journal:  Neurosurgery       Date:  1982-04       Impact factor: 4.654

6.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

7.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

8.  Correlates of survival and the Daumas-Duport grading system for astrocytomas.

Authors:  T S Kim; A L Halliday; E T Hedley-Whyte; K Convery
Journal:  J Neurosurg       Date:  1991-01       Impact factor: 5.115

9.  Monitoring quality-of-life needs of cancer patients.

Authors:  G Christ; K Siegel
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

  9 in total
  5 in total

1.  Design, Synthesis, and Biological Evaluation of 1,2,4-Thiadiazole-1,2,4-Triazole Derivatives Bearing Amide Functionality as Anticancer Agents.

Authors:  Yazala Jyothsna Pragathi; Reddymasu Sreenivasulu; Deekala Veronica; Rudraraju Ramesh Raju
Journal:  Arab J Sci Eng       Date:  2020-05-22       Impact factor: 2.334

2.  Health-related quality of life among cancer patients and survivors and its relationship with current employment status.

Authors:  Woorim Kim; Kyu-Tae Han; Seungju Kim
Journal:  Support Care Cancer       Date:  2022-02-04       Impact factor: 3.603

3.  Quality of life versus length of life considerations in cancer patients: A systematic literature review.

Authors:  Anne Shrestha; Charlene Martin; Maria Burton; Stephen Walters; Karen Collins; Lynda Wyld
Journal:  Psychooncology       Date:  2019-05-15       Impact factor: 3.894

4.  Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review.

Authors:  Vanessa Arciero; Seanthel Delos Santos; Liza Koshy; Amanda Rahmadian; Ronak Saluja; Louis Everest; Ambica Parmar; Kelvin K W Chan
Journal:  JAMA Netw Open       Date:  2021-02-01

Review 5.  Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.

Authors:  David M Baguley; Pattarawadee Prayuenyong
Journal:  Cancer Chemother Pharmacol       Date:  2019-12-21       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.